Patent classifications
C08F20/60
HYPERBRANCHED CATIONIC MUSSEL-IMITATED POLYMER AND METHOD OF PREPARING THE SAME
The present invention discloses a hyperbranched cationic mussel-imitated polymer and a method of preparing the same. The hyperbranched polymer disclosed in the present invention has the excellent mussel-imitated non-selective adhesive property, good biocompatibility and adhesive strength adjustability. The method of the present invention comprises the following steps: (A) adding an initiator, a RAFT agent and a first reaction mixture to a vessel containing DMF to form a second reaction mixture; (B) stirring the second reaction mixture until homogenous, and introducing argon to a reaction system to remove oxygen in the reaction system; (C) heating and stirring the second reaction mixture to carry out a reaction; (D) after a product with a desired molecular weight being produced, the reaction system being exposed to air and cooled rapidly in a cold water bath to terminate the reaction; and (E) purifying the product to obtain the hyperbranched cationic mussel-imitated polymer.
SURFACE TREATMENT LIQUID AND HYDROPHILIC TREATMENT METHOD
An object is to provide a surface treatment liquid which can firmly bond, while coating the surface of a treatment target with an extremely thin film, a coating whose hydrophilicity is unlikely to be lowered even when the coating is brought into contact with fats and the like to the surface of the treatment target and a surface treatment method using the surface treatment liquid described above. In a surface treatment liquid containing a resin (A) and a solvent (S), as the resin (A), a resin is used which includes a constituent unit (a1) that includes an organic group including a quaternary ammonium cation group and having a sulfonic acid anion group at a terminal and that is derived from an N-substituted (meth) acrylamide, and includes a reactive silyl group in at least one of molecular chain terminals, the concentration of the resin (A) in the surface treatment liquid is less than 2 mass % and the pH of the surface treatment liquid is 4 or less.
SURFACE TREATMENT LIQUID AND HYDROPHILIC TREATMENT METHOD
An object is to provide a surface treatment liquid which can firmly bond, while coating the surface of a treatment target with an extremely thin film, a coating whose hydrophilicity is unlikely to be lowered even when the coating is brought into contact with fats and the like to the surface of the treatment target and a surface treatment method using the surface treatment liquid described above. In a surface treatment liquid containing a resin (A) and a solvent (S), as the resin (A), a resin is used which includes a constituent unit (a1) that includes an organic group including a quaternary ammonium cation group and having a sulfonic acid anion group at a terminal and that is derived from an N-substituted (meth) acrylamide, and includes a reactive silyl group in at least one of molecular chain terminals, the concentration of the resin (A) in the surface treatment liquid is less than 2 mass % and the pH of the surface treatment liquid is 4 or less.
Method for preparing C-H acidic (meth)acrylates
The invention relates to a method for preparing CH acidic (meth)acrylates and the uses thereof.
Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase
The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R.sup.2, R.sup.3, R.sup.10, E.sup.1, E.sup.2, E.sup.3, Y, and Z are as defined herein. ##STR00001##
Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase
The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R.sup.2, R.sup.3, R.sup.10, E.sup.1, E.sup.2, E.sup.3, Y, and Z are as defined herein. ##STR00001##
Composition for polymerization, method for producing same, composition for a coating containing composition for polymerization, method for producing composition for a coating using composition for polymerization, and method for producing coating
A composition for polymerization, which can improve the storage stability in a high-temperature environment when a specific sulfobetaine monomer is stored as powder and can inhibit the discoloration of a cured film when the monomer is made into a cured film, and a method for producing the composition for polymerization; a composition for a coating containing the composition for polymerization, a method for producing the composition for a coating using the composition for polymerization, and a method for producing a coating; the composition for polymerization contains a monomer represented by formula (I) and water, in which the moisture content is equal to or higher than 3% by mass and less than 10% by mass ##STR00001##
Composition for polymerization, method for producing same, composition for a coating containing composition for polymerization, method for producing composition for a coating using composition for polymerization, and method for producing coating
A composition for polymerization, which can improve the storage stability in a high-temperature environment when a specific sulfobetaine monomer is stored as powder and can inhibit the discoloration of a cured film when the monomer is made into a cured film, and a method for producing the composition for polymerization; a composition for a coating containing the composition for polymerization, a method for producing the composition for a coating using the composition for polymerization, and a method for producing a coating; the composition for polymerization contains a monomer represented by formula (I) and water, in which the moisture content is equal to or higher than 3% by mass and less than 10% by mass ##STR00001##
Polymer glass transition temperature manipulation via z/e hydrazone photoswitching
In an embodiment, the present disclosure pertains to a method of changing the glass transition temperature of a polymer. In some embodiments, the polymer includes at least one hydrazone-containing compound. In general, the methods of the present disclosure include one or more of the following steps of: (1) applying light to the polymer; and (2) thereby changing the glass transition temperature of the polymer. In another embodiment, the present disclosure pertains to a polymer having a light-adjustable glass transition temperature. In some embodiments, the polymer includes at least one hydrazone-containing compound.
MATERIAL NON-ADHESIVE TO BIOLOGICAL SUBSTANCE, CURABLE COMPOSITION, AND ARTIFICIAL ORGAN AND MEDICAL INSTRUMENT USING SAME
A material non-adhesive to a biological substance containing: a polymer compound (A) which includes a repeating unit derived from a sulfobetaine monomer represented by Formula (I) or (II).
##STR00001##
In the formulae, R.sup.1 represents a methyl group, an ethyl group, an n-propyl group, or an isopropyl group, a plurality of R.sup.1's may be the same as or different from each other.
R.sup.2 represents a hydrogen atom or a methyl group.
n represents an integer of 2 to 4.
L represents a linear or branched alkylene group having 3 or 4 carbon atoms.